
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1019 | 977 | 1019 | 942 | 1100 | 1916 |
Fund Return | 1.87% | -2.26% | 1.87% | -1.97% | 1.92% | 6.72% |
Place in category | 330 | 257 | 330 | 244 | 185 | 54 |
% in Category | 89 | 68 | 89 | 72 | 64 | 24 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Liontrust Special Situations Fund A | 3.69M | 2.68 | 1.89 | 7.53 | ||
Liontrust Special Situations Fund I | 1.6B | -0.13 | 2.54 | 7.04 | ||
Liontrust European Growth Fund I In | 768.16M | 8.55 | 11.51 | 12.26 | ||
Liontrust European Growth Fund A In | 9.09M | 7.91 | 10.00 | 12.06 | ||
GB0030030174 | 359.71M | 9.27 | -0.04 | 12.01 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Artemis UK Select Fund I Acc | 2.04B | 8.79 | 15.31 | 9.83 | ||
Artemis UK Select Fund I Inc GBP | 235.04M | 25.31 | 10.43 | 9.44 | ||
Artemis UK Select Fund G Inc GBP | 813.31M | 5.79 | 13.25 | - | ||
Artemis UK Select Fund R Acc | 228.89M | 5.69 | 12.10 | 9.10 | ||
Fidelity Special Situations Fund W | 3.29B | 3.77 | 8.82 | 7.98 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 3.54 | 11,416.0 | +1.96% | |
Compass | GB00BD6K4575 | 3.51 | 2,562.00 | -0.12% | |
Relx | GB00B2B0DG97 | 3.49 | 3,887.00 | +0.70% | |
Unilever | GB00B10RZP78 | 3.45 | 54.86 | +1.22% | |
Shell | GB00BP6MXD84 | 3.41 | 33.58 | -1.50% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review